C1q and central nervous system disorders

被引:22
|
作者
Zhang, Wenjie [1 ,2 ]
Chen, Yuan [3 ]
Pei, Hui [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Emergency, Intens Care Unit, Zhengzhou, Peoples R China
[2] Xingyang Sishui Cent Hlth Ctr, Dept Gen Practice, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
c1q; central nervous system; neurodevelopment; degenerative diseases; inflammatory diseases; glioma; GUILLAIN-BARRE-SYNDROME; TRAUMATIC BRAIN-INJURY; COMPLEMENT PROTEIN C1Q; MOUSE MODEL; SPINAL-CORD; COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; PATHWAY ACTIVATION; CLASSICAL PATHWAY; UP-REGULATION;
D O I
10.3389/fimmu.2023.1145649
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
C1q is a crucial component of the complement system, which is activated through the classical pathway to perform non-specific immune functions, serving as the first line of defense against pathogens. C1q can also bind to specific receptors to carry out immune and other functions, playing a vital role in maintaining immune homeostasis and normal physiological functions. In the developing central nervous system (CNS), C1q functions in synapse formation and pruning, serving as a key player in the development and homeostasis of neuronal networks in the CNS. C1q has a close relationship with microglia and astrocytes, and under their influence, C1q may contribute to the development of CNS disorders. Furthermore, C1q can also have independent effects on neurological disorders, producing either beneficial or detrimental outcomes. Most of the evidence for these functions comes from animal models, with some also from human specimen studies. C1q is now emerging as a promising target for the treatment of a variety of diseases, and clinical trials are already underway for CNS disorders. This article highlights the role of C1q in CNS diseases, offering new directions for the diagnosis and treatment of these conditions.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] The intestinal barrier in disorders of the central nervous system
    Pellegrini, Carolina
    Fornai, Matteo
    D'Antongiovanni, Vanessa
    Antonioli, Luca
    Bernardini, Nunzia
    Derkinderen, Pascal
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (01): : 66 - 80
  • [32] Headache and inflammatory disorders of the central nervous system
    L. La Mantia
    A. Erbetta
    Neurological Sciences, 2004, 25 : s148 - s153
  • [33] [Central nervous system disorders diagnosed in dogs]
    Frade, Maria T. S.
    Ferreira, Jefferson S.
    Nascimento, Maria J. R.
    Aquino, Vitoria V. F.
    Macedo, Isabel L.
    Carneiro, Rosileide S.
    Souza, Almir P.
    Dantas, Antonio F. M.
    PESQUISA VETERINARIA BRASILEIRA, 2018, 38 (05): : 935 - 948
  • [34] The role of microbiome in central nervous system disorders
    Wang, Yan
    Kasper, Lloyd H.
    BRAIN BEHAVIOR AND IMMUNITY, 2014, 38 : 1 - 12
  • [35] MRA in inflammatory disorders of the central nervous system
    Felber, S
    Auer, A
    Schmutzhard, E
    RADIOLOGE, 2000, 40 (11): : 1077 - 1089
  • [36] Microdialysis in central nervous system disorders and their treatment
    McAdoo, David J.
    Wu, Ping
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2008, 90 (02) : 282 - 296
  • [37] The Role of Extracellular Vesicles and Microparticles in Central Nervous System Disorders: Mechanisms, Biomarkers, and Therapeutic Potential
    Najdaghi, Soroush
    Davani, Delaram Narimani
    Fouladseresht, Hamed
    Ebrahimi, Narges
    Sullman, Mark J. M.
    Moradi, Marjan
    Eskandari, Nahid
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2024, 44 (01)
  • [38] Central nervous system disorders on lorlatinib: How to detect and manage in practice?
    Fallet, Vincent
    Rouby, Pascal
    Ahle, Guido
    Arrondeau, Jennifer
    Naltet, Charles
    Duflot-Boukobza, Adeline
    De Crozals, Francoise
    Lena, Herve
    Cortot, Alexis
    BULLETIN DU CANCER, 2022, 109 (04) : 477 - 490
  • [39] Overview of the meningeal lymphatic vessels in aging and central nervous system disorders
    Jiang, Huimin
    Wei, Huimin
    Zhou, Yifan
    Xiao, Xuechun
    Zhou, Chen
    Ji, Xunming
    CELL AND BIOSCIENCE, 2022, 12 (01)
  • [40] Cell therapy for central nervous system disorders: Current obstacles to progress
    Yasuhara, Takao
    Kawauchi, Satoshi
    Kin, Kyohei
    Morimoto, Jun
    Kameda, Masahiro
    Sasaki, Tatsuya
    Bonsack, Brooke
    Kingsbury, Chase
    Tajiri, Naoki
    Borlongan, Cesario V.
    Date, Isao
    CNS NEUROSCIENCE & THERAPEUTICS, 2020, 26 (06) : 595 - 602